# OnCo record b-trial-diversity (bottleneck). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/bottlenecks/b-trial-diversity/>
  a schema:Thing ;
  onco:kind "bottleneck" ;
  schema:identifier "b-trial-diversity" ;
  schema:name "Trials do not represent the people who get cancer"@en ;
  schema:description "Older, Black, Hispanic, Asian, rural, poor and multimorbid patients are under-represented, so results may not apply to them."@en ;
  schema:url <https://onco.cc/bottlenecks/b-trial-diversity/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2019.1870>, <https://web.archive.org/web/20240415200043/https://www.fda.gov/about-fda/oncology-center-excellence/project-equity>, <https://doi.org/10.1056/NEJM199912303412706> ;
  onco:related <https://onco.cc/collections/fda-approvals/>, <https://onco.cc/collections/clinicaltrials-gov/>, <https://onco.cc/ideas/idea-tr1-diversity-plans-with-consequences/>, <https://onco.cc/ideas/idea-tr1-ancestry-aware-pharmacology-programme/>, <https://onco.cc/ideas/idea-tr1-duffy-null-neutrophil-threshold/>, <https://onco.cc/ideas/idea-tr1-mandatory-older-adult-cohort/>, <https://onco.cc/ideas/idea-tr1-parallel-comorbidity-cohorts/>, <https://onco.cc/ideas/idea-tr1-lmic-sites-in-pivotal-trials/>, <https://onco.cc/ideas/idea-tr1-community-health-worker-recruitment/>, <https://onco.cc/ideas/idea-tr1-language-access-in-trials/>, <https://onco.cc/ideas/idea-tr1-site-equity-index/>, <https://onco.cc/ideas/idea-tr1-include-pregnancy-capable-people-sensibly/>, <https://onco.cc/ideas/idea-tr1-age-floor-twelve-for-adult-trials/>, <https://onco.cc/ideas/idea-tr1-sex-stratified-pk-and-dosing/>, <https://onco.cc/ideas/idea-tr1-disability-and-mental-illness-inclusion/>, <https://onco.cc/ideas/idea-tr1-representativeness-in-the-label/>, <https://onco.cc/ideas/idea-tr1-diverse-investigator-pipeline/>, <https://onco.cc/ideas/idea-tr1-paid-community-advisory-boards/>, <https://onco.cc/ideas/idea-tr1-post-marketing-safety-by-ancestry-and-sex/>, <https://onco.cc/ideas/idea-tr1-ecog-2-dedicated-cohorts/>, <https://onco.cc/ideas/idea-tr1-trial-desert-map/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/gastric/> ;
  onco:technologies <https://onco.cc/technologies/geriatric-assessment/>, <https://onco.cc/technologies/ai-trial-matching/> ;
  onco:companies <https://onco.cc/companies/swog/>, <https://onco.cc/companies/ecog-acrin/>, <https://onco.cc/companies/hengrui/>, <https://onco.cc/companies/akeso/>, <https://onco.cc/companies/beone/> ;
  onco:institutions <https://onco.cc/institutions/nci/>, <https://onco.cc/institutions/asco/>, <https://onco.cc/institutions/sysucc/>, <https://onco.cc/institutions/tata-memorial/>, <https://onco.cc/institutions/cams-cancer-hospital/> ;
  onco:terms <https://onco.cc/terms/egfr-exon19-l858r/>, <https://onco.cc/terms/hazard-ratio/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-loree-jama-oncol/>, <https://onco.cc/key-papers/paper-hutchins-n-engl-j-med/> .